Page last updated: 2024-11-05

tranexamic acid and Pulmonary Aspergillosis

tranexamic acid has been researched along with Pulmonary Aspergillosis in 1 studies

Tranexamic Acid: Antifibrinolytic hemostatic used in severe hemorrhage.

Pulmonary Aspergillosis: Infections of the respiratory tract with fungi of the genus ASPERGILLUS.

Research Excerpts

ExcerptRelevanceReference
"Subacute invasive pulmonary aspergillosis (formerly called chronic necrotising pulmonary aspergillosis) is a more rapidly progressive infection (<3 months) usually found in moderately immunocompromised patients, which should be managed as invasive aspergillosis."1.43Chronic pulmonary aspergillosis: rationale and clinical guidelines for diagnosis and management. ( Ader, F; Beigelman-Aubry, C; Blot, S; Cadranel, J; Chakrabarti, A; Denning, DW; Dimopoulos, G; Lange, C; Ullmann, AJ, 2016)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Denning, DW1
Cadranel, J1
Beigelman-Aubry, C1
Ader, F1
Chakrabarti, A1
Blot, S1
Ullmann, AJ1
Dimopoulos, G1
Lange, C1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Aspergillus-specific IgG Assays for the Diagnosis of Chronic Pulmonary Aspergillosis (CPA) in Chinese Patients -Multicenter Study[NCT03027089]560 participants (Anticipated)Observational2017-01-31Recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Other Studies

1 other study available for tranexamic acid and Pulmonary Aspergillosis

ArticleYear
Chronic pulmonary aspergillosis: rationale and clinical guidelines for diagnosis and management.
    The European respiratory journal, 2016, Volume: 47, Issue:1

    Topics: Antifibrinolytic Agents; Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Bronchial Arte

2016